Study Shows Differences In Natural Immunity In Cloned Pigs

Article

Studies by scientists with the U.S. Department of Agriculture and the University of Missouri indicate that the natural immune system of young cloned pigs does not appear to fight diseases as effectively as the immune system of non-cloned pigs.

 

Animal physiologist Jeff Carroll of USDA's Agricultural Research Service collaborated with University of Missouri-Columbia scientists Bart Carter, Randall Prather and Scott Korte on the study. The pigs were cloned at the University of Missouri by Prather and his colleagues. ARS is USDA's chief scientific research agency. At the time of the study, Carroll worked at ARS' Animal Physiology Research Unit in Columbia, but he is now based at the agency's Livestock Issues Research Unit in Lubbock, Texas.

 

In their experiments, the scientists gave a naturally occurring toxin called lipopolysaccharide to seven young, cloned pigs and 11 genetically similar, non-cloned pigs. Although the non-cloned pigs' immune response was adequate, the cloned pigs' immune system did not produce sufficient quantities of natural proteins called cytokines, which fight infections. Animals must have an adequate cytokine response to survive infections.


Cloned pigs, as well as cloned cows, have been known to have a higher-than-normal number of deaths around the time of birth. Many die from bacterial infections.

 

As newborns, both the cloned and non-cloned pigs received some disease protection through their consumption of colostrum, a natural substance passed to a newborn pig via its mother's milk. The colostrum helps protect the young animal until its own immune system begins to function.

 

The cloned pigs are being used only for research purposes, and are not part of the food supply.


Source: USDA/Agricultural Research Service

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content